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End-of-life care for cancer patients in TaiwanDear Editor,
Two papers published recently in Journal of the Formosan
Medical Association highlight the increased recognition of
the importance of end-of-life care for cancer patients in
Taiwan.1,2 According to a population-based study, aggres-
sive end-of-life care was associated with male sex, younger
age, hematologic malignancies, co-morbid diseases,
admission to hospitals with abundant health care resources,
and primary care by oncologists.3,4 While these studies may
help improve the quality of end-of-life care and rational
allocation of health resources, several issues should be
addressed to apply the results of these studies in clinical
practice.
The first is the definition of quality indicators. The most
commonly used quality indicators of end-of-life care
include adequacy of pain management, referral to hospice
care, and administration of chemotherapy during the end-
of-life period.5 This last point should be clarified further. In
Taiwan, most patients with advanced or terminal cancers
are referred to oncologists, who are expected by the
patients, their families, and the referring physicians to give
chemotherapy both for life prolongation and for symp-
tomatic control.3 Therefore, the more common use of
chemotherapy by oncologists in Taiwan may reflect the
practice patterns rather than the quality of end-of-life
care.1,3 To clarify this issue, future studies should analyze
the use of chemotherapy in the context of current treat-
ment guidelines for individual cancers. The causes of death
(tumor progression, co-morbidities, or treatment compli-
cations) should also be identified.
The second issue is the importance of early incorpora-
tion of palliative care early in the course of cancer treat-
ment. Studies in metastatic lung cancer patients showed
that incorporation of palliative care at the time of diagnosis
by a specialized team can significantly improve survival and
patient satisfaction.6 Moreover, patients who received
early palliative care had better understanding of their
prognoses and were less likely to receive chemotherapy
near the end of life.7 Future strategies of palliative care0929-6646/$ - see front matter Copyright ª 2011, Elsevier Taiwan LLC
doi:10.1016/j.jfma.2011.11.015for cancer patients in Taiwan should go beyond the
‘end-of-life’ settings and be incorporated into networks of
multi-disciplinary cancer care.
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